Examination for patients with bone metastatic Castration resistant prostate cancer to predict Overall survival and Treatment efficacy by bone Scan index Use study

Examination for patients with bone metastatic Castration resistant prostate cancer to predict Overall survival and Treatment efficacy by bone Scan index Use study - COTSU study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041830

Enrollment

Registered

2020-10-01

Start date

2020-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Castration resistant prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with bone metastatic castration-resistant prostate cancer

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The association between VSBONE BSI index and progression-free survival	—

Countries

Japan

Contacts

Public ContactShunta Hori

Nara Medical University Urology

urology@naramed-u.ac.jp634-8522

Outcome results